President Donald Trump’s stance on legalizing medical cannabis is a big question mark, and Attorney General Jeff Sessions hates marijuana and has expressed his intent to stiffen drug penalties. But there is at least one person in the government who sees the potential of marijuana as a medicine, and that person is Veterans Affairs (VA) Secretary David Shulkin.
Polychlorinated biphenyls, or PCBs, have been banned in the United States since 1979, but a new study by researchers at Harvard’s T.H. Chan School of Public Health shows that up to 14 million students in 26,000 U.S. public schools may still be exposed to the toxic industrial chemicals. [1
Antitobacco groups have decided to file a lawsuit against the U.S. Food and Drug Administration (FDA) over the agency’s delay in issuing a final rule about graphic health warnings on cigarette packs and ads. [1]
The legal action was launched October 4 in federal court in Boston by the following groups, as well as several pediatricians:
Just recently, the Drug Enforcement Administration (DEA) said it would not reschedule marijuana from a Schedule I drug to a Schedule II drug. However, the agency said it would try to make it easier for scientists and companies to access marijuana for research.
Many hoped that the Obama administration would reschedule marijuana from a Schedule I substance to a Schedule II substance this year, but no such luck. The Drug Enforcement Administration (DEA) also announced on August 11 that marijuana would remain illegal under federal law. Other Schedule I substances include heroin, LSD, peyote, ecstasy, quaaludes, and bath salts, among others. [1]
Right now, the Drug Enforcement Agency (DEA) classifies marijuana as a Schedule I drug, right alongside heroin, LSD, peyote, and ecstasy. That’s more than a little ridiculous, considering Schedule I drugs are classified as such because they have “no medical use and a high potential for abuse.”
We know that marijuana does, in fact, have numerous medical uses.
